Full Name
Dr. Arturo Loaiza-Bonilla FACP, MD
Job Title
Medical Director of Oncology Research
Practice/Company Name
Capital Health
Speaker Bio
Dr. Arturo Loaiza-Bonilla, MD, MSEd, is the Co-Founder and Chief Medical Officer at Massive Bio, a global industry leader in connecting patients to clinical trials using artificial intelligence. An internationally renowned medical oncologist and researcher, Dr. Bonilla has a distinguished academic and clinical career in precision medicine oncology, immunotherapy, clinical trial design, digital health, entrepreneurship, and patient advocacy. Dr. Loaiza-Bonilla is board certified in both medical oncology and hematology and has extensive experience in the diagnosis and treatment of genomic biomarker-driven cancers and serves as enterprise Medical Director of Oncology Research at Capital Health, focused in Gastrointestinal Malignancies and Biomarkers.
Dr. Loaiza-Bonilla earned a medical degree from the Universidad Nacional de Colombia in Bogotá, Colombia. Following medical school, he completed an internship and residency in internal medicine at Harbor Hospital Center, Johns Hopkins Hospital in Baltimore, Maryland. Dr. Loaiza-Bonilla also completed a fellowship in hematology and oncology from the University of Miami, Miller School of Medicine in Miami, Florida. He completed his master’s degree in medical education at the University of Pennsylvania, and pursued professional certification in Artificial Intelligence in healthcare at the MIT Sloan School of Management.
Before joining Capital Health, Dr. Loaiza-Bonilla was vice chairman of the Department of Medical Oncology at Cancer Treatment Centers of America in Philadelphia, Pennsylvania, as well as enterprise director of research, where he provided leadership and expertise to their oncology trial portfolio across 5 cancer centers and over 70 NCTN and industry-sponsored clinical trials. His research has been extensively published in the most prominent journals and meetings in oncology, and he has been recipient of NIH funding to advance digital health and artificial intelligence tools for cancer research. He was also assistant professor of Clinical Medicine at the University of Pennsylvania School of Medicine; and he is currently assistant professor in the Department of Medicine at Drexel University College of Medicine, both in Philadelphia.
Throughout his stellar career, Dr. Loaiza-Bonilla has held numerous leadership positions such as President of the Pennsylvania Society of Oncology and Hematology and President of the Board of Directors of the Global Alliance for Patient Access. In 2018, he was recognized as Philadelphia Business Journal’s Forty Under 40, in 2019 he was bestowed the Influencers of Healthcare Award – Outstanding Healthcare Provider award by the Philadelphia Inquirer, and in 2021 he was chosen as recipient of '40 under 40 in Cancer' accolade. He has also been selected in Castle Connolly's and Philadelphia Magazine's Top Doctors listing since 2018.
Dr. Loaiza-Bonilla earned a medical degree from the Universidad Nacional de Colombia in Bogotá, Colombia. Following medical school, he completed an internship and residency in internal medicine at Harbor Hospital Center, Johns Hopkins Hospital in Baltimore, Maryland. Dr. Loaiza-Bonilla also completed a fellowship in hematology and oncology from the University of Miami, Miller School of Medicine in Miami, Florida. He completed his master’s degree in medical education at the University of Pennsylvania, and pursued professional certification in Artificial Intelligence in healthcare at the MIT Sloan School of Management.
Before joining Capital Health, Dr. Loaiza-Bonilla was vice chairman of the Department of Medical Oncology at Cancer Treatment Centers of America in Philadelphia, Pennsylvania, as well as enterprise director of research, where he provided leadership and expertise to their oncology trial portfolio across 5 cancer centers and over 70 NCTN and industry-sponsored clinical trials. His research has been extensively published in the most prominent journals and meetings in oncology, and he has been recipient of NIH funding to advance digital health and artificial intelligence tools for cancer research. He was also assistant professor of Clinical Medicine at the University of Pennsylvania School of Medicine; and he is currently assistant professor in the Department of Medicine at Drexel University College of Medicine, both in Philadelphia.
Throughout his stellar career, Dr. Loaiza-Bonilla has held numerous leadership positions such as President of the Pennsylvania Society of Oncology and Hematology and President of the Board of Directors of the Global Alliance for Patient Access. In 2018, he was recognized as Philadelphia Business Journal’s Forty Under 40, in 2019 he was bestowed the Influencers of Healthcare Award – Outstanding Healthcare Provider award by the Philadelphia Inquirer, and in 2021 he was chosen as recipient of '40 under 40 in Cancer' accolade. He has also been selected in Castle Connolly's and Philadelphia Magazine's Top Doctors listing since 2018.
Speaking At
